New York State Common Retirement Fund Protagonist Therapeutics, Inc Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 17,882 shares of PTGX stock, worth $819,889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,882
Previous 20,182
11.4%
Holding current value
$819,889
Previous $908,000
24.01%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding PTGX
# of Institutions
253Shares Held
58MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$272 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$264 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$252 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$193 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$153 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.25B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...